Cytokinetics Inc
Sector:
Industry:
65.35
0.55
(0.849%)
Volume:
640,663
52 week range:
25.98 - 110.25
Market Cap:
6.834B
Company Description:
cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. as a leader in muscle biology and the mechanics of muscle performance, we're developing small molecule drug candidates specifically engineered to increase muscle function and contractility.